Showing results (101-110 of 245) with videos related to
Sort By:
Pageof 25
Plos One|January 11, 2020
Bioreactor for mobilization of mesenchymal stem/stromal cells into scaffolds under mechanical stimulation: Preliminary resultsCarolina Gamez, Barbara Schneider-Wald, Andy Schuette, et al.European Journal of Heart Failure|February 1, 2024
Transcatheter aortic valve replacement in heart failurePuja B Parikh, Michael Mack, Gregg W Stone, et al.Journal of the American College of Cardiology|July 3, 2007
Valve-in-a-valve concept for transcatheter minimally invasive repeat xenograft implantationThomas Walther, Volkmar Falk, Todd Dewey, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 29, 2016
The value of surgeon-specific outcome data: results of a questionnaireMarjan Jahangiri, Rajdeep Bilkhu, Michael Borger, et al.The Annals of Thoracic Surgery|October 3, 2017
Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis and Mitral RegurgitationKreton Mavromatis, Vinod H Thourani, Amanda Stebbins, et al.JACC. Cardiovascular Interventions|March 11, 2017
Outcomes After Paravalvular Leak Closure: Transcatheter Versus Surgical ApproachesJohn A Wells, Jose F Condado, Norihiko Kamioka, et al.The Journal of Invasive Cardiology|October 2, 2003
The influence of diabetes mellitus on the practice and outcomes of percutaneous coronary intervention in the community: a report from the HCA databaseAaron D Kugelmass, David J Cohen, Frank Houser, et al.Circulation. Cardiovascular Interventions|August 14, 2023
Physician-Modified Endograft-Facilitated Transcatheter Pulmonary Valve Replacement in Large Right Ventricular Outflow TractHiroki A Ueyama, Adam B Greenbaum, Bradley G Leshnower, et al.JAMA Cardiology|May 4, 2017
Association of Transcatheter Aortic Valve Replacement With 30-Day Renal Function and 1-Year Outcomes Among Patients Presenting With Compromised Baseline Renal Function: Experience From the PARTNER 1 Trial and RegistryNirat Beohar, Darshan Doshi, Vinod Thourani, et al.Arthritis and Rheumatism|April 1, 2009
Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled studyArthur Kavanaugh, Iain McInnes, Philip Mease, et al.Pageof 25